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Abstract 
 Occupational health surveillance programs are designed to evaluate and reduce 
injury, illness, and deaths related to workplace hazards.  In the state of Florida, there are 
numerous industries where workers are potentially exposed to airborne hazards from 
gases, vapors and dusts.  Airborne occupational exposures to irritants, vesicants, and 
fibrogens have the potential to cause pulmonary function impairment if exposures are not 
properly controlled for high-level acute exposure as well as chronic exposure.  For 
occupations that demand workers be exposed to substances known to be associated with 
pulmonary function impairment, respirators may be a principal method for exposure 
control.  OSHA requires pulmonary function testing for specific substances and it is a 
best practice that is utilized in a majority of occupational settings and is typically 
included in an organizations respiratory protection program.  A literature review 
identified that boat manufacturing, utilities, and first responders in the State of Florida 
have the potential for increased pulmonary impairment amongst workers.  This research 
demonstrated the feasibility of using pulmonary function data collected for the purposes 
of compliance and/or best practices for workers who use respiratory protection because 
they are potentially exposed to pulmonary toxicants in the workplace.  This research did 
not identify any pulmonary function deficits in the target occupational populations and it 
demonstrated that in most cases, the study populations had modestly superior pulmonary 
function compared to a baseline population. 
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Chapter 1 
Introduction 
Occupational health surveillance programs are designed to evaluate and reduce 
injury, illness, and deaths related to workplace hazards.  Since potential adverse health 
effects may not present for many years, it is imperative that surveillance tools be 
developed and utilized to identify potential hazards in the workplace before they cause 
substantial and potentially irreversible health outcomes.  Proven methods and procedures 
used to capture critical occupational health data is the basis for an effective surveillance 
program.  Alli (2008) states: 
Workers’ health surveillance entails procedures for the assessment of 
workers’ health by means of detection and identification of any abnormalities. 
Such procedures may include biological monitoring, medical examinations, 
questionnaires, radiological examinations and reviews of workers’ health records, 
among others. 
The National Institute for Occupational Safety and Health (NIOSH) has 
recognized the importance for in-depth investigations and prevention aimed at particular 
diseases, injuries, hazards, and specific worker populations.  Occupational health 
surveillance has been a priority at NIOSH since its inception by the Occupational Safety 
and Health Act in 1970.  Since that time, NIOSH has been able to identify areas that need 
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additional research and prevention efforts for both existing and new problems alike. 
NIOSH (2012a) has established that data and information derived from surveillance can 
be used to: 
• Guide immediate action for cases of public health importance 
• Measure the burden of an injury or disease including changes in related 
factors, the identification of populations at high risk, and the identification of 
new or emerging health concerns 
• Guide the planning, implementation, and evaluation of programs to prevent 
and control injuries, disease, or adverse exposures 
• Evaluate public policy 
• Detect changes in health practices and the effects of the changes 
• Prioritize the allocation of health resources 
• Describe the clinical course of disease 
• Provide a basis for epidemiologic research 
While NIOSH has made significant progress in helping reduce work-related 
diseases and injuries, occupational health surveillance in the United States is not 
consistent and data gaps exist.  Baker et al. (1988) recognized such deficiencies and 
stated: 
 Unfortunately, in the minds of many occupational health professionals, 
surveillance systems are viewed as passive and ponderous systems designed to 
collect information of uncertain utility.  To achieve a broader involvement of 
occupational health professionals in surveillance of occupational disorders, 
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systems must be developed that are intrinsically active and allow for rapid 
response to emerging trends of illness and injury. 
This recognition by NIOSH and other public health professionals has led to the 
development and continued funding of state-based occupational safety and health 
surveillance programs.  These state-based surveillance programs use existing reporting 
systems to collect data on occupational safety and health hazards and effects; identify 
new sources of data; conduct surveillance; interpret findings; and develop and/or 
recommend interventions (NIOSH, 2012b).  Currently, NIOSH is providing financial and 
technical assistance for twenty-three state-based surveillance programs.  These states 
include California, Colorado, Connecticut, Florida, Georgia, Illinois, Iowa, Kentucky, 
Louisiana, Maryland, Massachusetts, Michigan, Minnesota, Nebraska, New Hampshire, 
New Jersey, New Mexico, New York State, North Carolina, Oregon, Texas, Washington, 
and Wisconsin.  
Part of the strategic plan for NIOSH includes the development and expansion of 
mechanisms for occupational health surveillance on both the state and federal levels 
(NIOSH, 2012c).  It is clear that there is a continued need to develop and utilize 
surveillance methodologies that are capable of efficiently evaluating occupational 
populations for health status, identifying changes in health status over time, and 
comparing the health status of occupational populations to baseline populations.  The use 
of existing health data to quickly evaluate the health status of a population provides 
efficiency in both cost and time by limiting the need to perform prospective data 
collection on a population of interest. 
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Florida is one of the twenty-three states receiving financial and technical 
assistance from NIOSH for a state-based occupational safety and health surveillance 
program.  The ultimate goal of the program is to continually improve the overall health of 
the workforce in the state. A preliminary description of the NIOSH state-based 
surveillance program for Florida is as follows (NIOSH, 2012b): 
The Florida Department of Health, Division of Environmental Health, 
Bureau of Environmental Public Health Medicine (EPHM) will develop and 
implement a Fundamental State-Based Occupational Safety and Health 
Surveillance Program by collecting and analyzing various data sets including data 
from the Bureau of Labor Statistics and Surveys, Florida hospital discharge, 
ambulatory and emergency departments, vital statistics death file, Florida Cancer 
Registry, census information and other data sources in order to produce and 
disseminate information on the Centers for Disease Control and Prevention 
(CDC)/Council of State and Territorial Epidemiologists (CSTE) occupational 
health indicators relevant to Florida.  Additionally, EPHM will work 
collaboratively with numerous partners including universities, local, state, and 
federal agencies to identify new data sources to enhance ongoing surveillance 
activities.  EPHM plans to use these data sources to gain a better understanding of 
the health impact of occupational exposures and injuries in Florida. EPHM will 
compare Florida's experience with statistics from other states in order to develop a 
better overall view of Florida's experience compared to the nation.  Florida also 
plans to convene an Occupational Health Surveillance Program Advisory Board.  
This group will have representatives from clinical medicine, public health, 
5"
"
academia, and industry in Florida and will serve to guide the program in its efforts 
and help to prioritize surveillance efforts, disseminate findings and participate in 
research and prevention activities.  EPHM plans to form a collaborative 
partnership with the University of South Florida's OSHA Training Institute 
Education Center to identify occupations and industries that would benefit from 
more in-depth surveys and investigations designed to identify interventions that 
reduce workplace morbidity. 
In the state of Florida, there are numerous industries where workers are 
potentially exposed to airborne hazards from gases, vapors, and dusts.  Airborne 
occupational exposures to irritants, vesicants, and fibrogens have the potential to cause 
pulmonary function impairment if exposures are not properly controlled for high-level 
acute exposure as well as extended periods of time.   
For occupations that demand workers be exposed to substances known to be 
associated with pulmonary function impairment, respirators may be a principal method 
for exposure control.  Therefore, governmental standards have been established to ensure 
the protection of workers when the elimination of the airborne hazard cannot be removed 
and engineering controls are not possible.  Occupational Safety and Health 
Administration (OSHA) Respirator Protection Standard 1910.134 (OSHA, 2012a) states:  
In the control of those occupational diseases caused by breathing air 
contaminated with harmful dusts, fogs, fumes, mists, gases, smokes, sprays, or 
vapors, the primary objective shall be to prevent atmospheric contamination.  This 
shall be accomplished as far as feasible by accepted engineering control measures 
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(for example, enclosure or confinement of the operation, general and local 
ventilation, and substitution of less toxic materials).  When effective engineering 
controls are not feasible, or while they are being instituted, appropriate respirators 
shall be used pursuant to this section. 
 When respirators are required to be used in the workplace, it is universally 
recognized that a respiratory protection program be established.  The safe use of a 
respirator requires at a minimum that the following program elements be addressed 
(Colton & Nelson, 2003): 
• Program administration 
• Written work site specific operating procedures 
• Exposure assessment 
• Medical evaluation of respirator wearers 
• Proper selection of respiratory protective equipment 
• Training 
• Respirator fitting 
• Cleaning, inspection, maintenance, and storage 
• Program evaluation 
As stated above, a medical evaluation of respirator wearers is a required element 
of a respiratory protection program.  To comply with this requirement, employees may be 
required to undergo pulmonary function testing to determine if they are able to safely 
wear a respirator.  It is important to note that the respiratory protection standard only 
requires a physician to establish the necessary health and physical conditions for a worker 
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to be able to perform their assigned job functions while wearing a respirator. It does not 
make it mandatory to administer a particular evaluation procedure, such as a pulmonary 
function test unless it is required in the provisions of specific OSHA standards.   
OSHA substance specific standards such as Asbestos (1910.1001), Cadmium 
(1910.1027), Coke Oven Emissions (1910.1029), Cotton Dust (1910.1043), Benzene 
(1910.1028), and Formaldehyde (1910.1048) require pulmonary function tests as part of 
the medical evaluation and are to include forced vital capacity (FVC) and forced 
expiratory volume at one second (FEV1).  Some of these substance specific standards 
have detailed sections that present pulmonary function testing requirements while other 
specific standards include pulmonary function testing as part of the medical surveillance 
requirements.  For example, the pulmonary function standard for Cotton Dust 
(1910.1043) includes sections regarding the apparatus, the technique for measurement of 
forced vital capacity maneuver, the interpretation of the spirogram, and the qualifications 
of personnel administering the test.  The Interpretation of Spirogram section presented in 
Cotton Dust (1910.1043) Appendix D (OSHA, 2012b) is as follows: 
• The first step in evaluating a spirogram should be to determine whether or not 
the patient has performed the test properly or as described in II above.  From 
the three satisfactory tracings, the FVC and FEV1 shall be measured and 
recorded.  The largest observed FVC and largest observed FEV1 shall be used 
in the analysis regardless of the curve(s) on which they occur. 
• The following guidelines are recommended by NIOSH for the evaluation and 
management of workers exposed to cotton dust.  It is important to note that 
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employees who show reductions in FEV1/FVC ratio below .75 or drops in 
Monday FEV1 of five percent or greater on their initial screening exam, 
should be re-evaluated within a month of the first exam.  Those who show 
consistent decrease in lung function, as shown on the following table, should 
be managed as recommended. 
Figure 1 presents an example of a spirogram with volumes and measurements including 
FVC and FEV1. 
 For other OSHA substance specific standards such as Benzene (1910.1028) 
(OSHA, 2012c), pulmonary function testing is covered under the medical surveillance 
section: 
• 1910.1028(i)(1)(iii) 
o The employer shall assure that persons other than licensed physicians 
who administer the pulmonary function testing required by this section 
shall complete a training course in spirometry sponsored by an 
appropriate governmental, academic or professional institution. 
• 1910.1028(i)(2)(i)(E) 
o For all workers required to wear respirators for at least thirty days a 
year, the physical examination shall pay special attention to the 
cardiopulmonary system and shall include a pulmonary function test. 
• 1910.1028(i)(3)(iii) 
o For persons required to use respirators for at least thirty days a year, a 
pulmonary function test shall be performed every three years.  A 
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specific evaluation of the cardiopulmonary system shall be made at the 
time of the pulmonary function test. 
Individual medical surveillance required by the respiratory protection program 
and substance specific standards provide an opportunity to collect group health 
information that can be integrated into an occupational health surveillance database.  
Pastides & Mundt (2003) state the importance of such information: 
 Surveillance, however, cannot be accomplished at the individual level, but 
becomes possible only when data from groups of employees are pooled and 
evaluated.  This group perspective is the fundamental attribute that launched 
epidemiology into the forefront of communicable disease research, and it 
continues to be a cornerstone of the profession today.  Typically, the rate or 
prevalence of disease, or prevalence of some indicator of exposure or risk, are 
compared among groups of employees or with some other referent group (such as 
the general population). 
 The development of an occupational health surveillance database and the 
subsequent use of such health data (pulmonary function tests) provide an opportunity to 
quickly evaluate the health status of a population in an efficient manner by limiting the 
need to perform prospective data collection on a population of interest. 
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Figure 1: Spirogram with Volume and Measurements.  FEF25-75, forced expiratory flow at 25%-75% vital capacity; FEV1, 
forced expiratory volume in 1 second; FVC, forced vital capacity.(Adapted from Siberry GK, Iannone R (Eds.) The Johns 
Hopkins Hospital Harriet Lane Handbook, 15th ed. St. Louis: Mosby, 1999.) 
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While pulmonary function testing is not required for all employees who wear 
respirators, it is a best practice that is utilized in a majority of occupational settings and is 
typically included in an organizations respiratory protection program.  Spirometry is the 
most frequently performed pulmonary function test and is the cornerstone of occupational 
respiratory evaluation programs (Townsend, 2011).   
In the occupational health setting, spirometry plays a critical role in the primary, 
secondary, and tertiary prevention of workplace-related lung disease (American College 
of Occupational and Environmental Medicine, 2000).  Spirometry data collected as a 
result of both standard medical practice and required testing provides a unique 
opportunity to perform occupational health surveillance among workers in targeted 
industrial occupations known to have potentially harmful exposures in the workplace.  It 
also provides another opportunity to perform a vital function of occupational health 
surveillance as identified by Markowitz (2007): 
Occupational health surveillance is an important means of discovering 
new associations between occupational agents and accompanying diseases.  The 
potential toxicity of approximately eighty percent of the chemicals used in the 
workplace has not been evaluated in humans or in in vivo or in vitro test systems.  
Discovery of rare diseases, patterns of common diseases, or suspicious exposure-
disease associations through surveillance activities in the workplace can provide 
vital leads for more conclusive scientific evaluation of the problem and possible 
verification of new occupational diseases. 
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Unfortunately, the vast majority of this data is used to simply validate individual 
capacity for respirator use and is ignored for population level analysis.  Determining 
whether such data can be used efficiently to conduct a population level analysis is in line 
with the directive of EPHM to identify new data sources to enhance ongoing surveillance 
activities with the ultimate goal of gaining a better understanding of the health impact of 
occupational exposures in Florida. 
The objectives of the current study are as follows: 
• Identify industries in the State of Florida that have the potential for increased 
pulmonary impairment amongst workers 
• Evaluate the feasibility of using pulmonary function data collected for purposes of 
compliance and/or best practices for workers who use respiratory protection 
because they are potentially exposed to pulmonary toxicants in the workplace 
This study will attempt to test the following hypothesis: 
• Pulmonary function is impaired among workers of selected industries exposed to 
various airborne toxicants 
13"
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Chapter 2 
Spirometry and Lung Function 
In order to evaluate the data produced from pulmonary function testing, it is 
important to have a basic understanding of lung function and how is it measured.  
Pulmonary function tests evaluate the functionality of the lungs.  Spirometry is the most 
basic type of pulmonary function test and provides air volume and flow rate within the 
lungs.  Schlegelmilch and Kramme state: 
Spirometers are noninvasive diagnostic instruments for screening and 
basic testing of pulmonary function.  Offering essential diagnostic insight into the 
type and extent of lung function impairment, spirometry tests can be performed 
fast at fairly low cost.  In the light of ever-increasing prevalence of airway 
diseases such as asthma, bronchitis, and emphysema, pulmonary function 
instruments have become indispensible diagnostic tools, in clinical and office 
settings, in industrial and preventive medicine, as well as in epidemiology. 
As mentioned in Chapter 1, spirometry is the most frequently performed 
pulmonary function test other than an arterial blood gas study and plays an important role 
in diagnosing the presence and type of lung ‘abnormality’ and classifying its severity 
(Sood et al., 2007).  The utility of spirometry as a tool to evaluate pulmonary health is 
further discussed by Petty (2005): 
14"
"
Normal spirometry predicts a high likelihood of long-time survival; 
abnormal spirometry indicates an adverse prognosis.  Simple spirometric 
measures provide an important database for the primary care physician and 
specialist.  One example is the patient who comes to the physician with cough and 
dyspnea thought to be associated with a certain occupation.  Knowledge of prior 
spirometry will give a baseline for comparison. 
Results of such testing that is already being collected for select occupational 
populations can be integrated into a functional database and used to conduct medical 
health surveillance in a cost effective and efficient manner. 
2.1 History of Spirometry 
Scientific inquiry into the understanding of lung function as a process, goes far 
back into history and has led scientists to develop various methods and instruments to 
measure lung capacity.  This was an important endeavor because measurement of lung 
volumes provides fundamental information that makes categorization and the staging of 
lung diseases possible.  The concept of spirometry has been traced back to a doctor 
named Claudius Galen who lived during the time of the Roman Empire.  He studied 
human ventilation by having a subject breathe into a bladder and discovered that over a 
period of time the volume of gas did not change. 
The next documented experiment involving lung volumes took place around 1681 
by a mathematician named Giovanni Alfonso Borelli.  His experiment involved having a 
subject suck liquid through a cylindrical glass tube.  The volume was calculated from the 
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bore of the tube and the height of the meniscus, which unfortunately led to a significant 
underestimation of true lung volumes (Garay, 2007).  In the early 1700s Stephen Hales 
confirmed the absolute measurements of air volume recorded by James Jurin in 1718.  He 
recorded the maximum volume of air, which could expire into a bladder using 
displacement of water according to the principle of Archimedes (Spriggs, 1978).   
While experiments were conducted in the past, the practice of determining lung 
volumes began to advance in the 17th century and continued to progress with the 
improvement of technology and data collection methods.  For example, in 1947 Tifineau 
introduced the concept of the timed vital capacity, which resulted in FEV1 (Petty, 2005).  
Since that time, spirometry has continued to evolve but still remains an easy and effective 
tool to measure pulmonary function.  Petty (2005) states: 
Spirometry is a highly useful, yet simple instrument for the measurement 
of expiratory air flow and volume.  Spirometry is key to the diagnosis of 
obstructive ventilatory diseases, that is, asthma and chronic obstructive 
pulmonary disease (COPD), and in monitoring responses to therapy.  Spirometry 
also identifies restrictive disease and helps monitor therapy and predicts prognosis 
over time.  
Table 1 presents some of the main contributors and significant achievements in 
the history of spirometry over the past two centuries. 
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Table 1: History of Spirometry 
Year  Contributor Achievement 
1800 Davy Measurement of residual volume using a hydrogen gas 
dilution technique. 
1844 Hutchinson Designed the first spirometer. Designated the expiratory 
vital capacity and developed normal standards based 
upon approximately 2,000 assorted English persons. 
1940s Cournand & 
Richards 
Established standard methods of assessment and 
published normal values of pulmonary function tests. 
1947 Tiffeneau & Pinelli Contributions to the measurement of timed vital 
capacity. 
1949 Tiffeneau, Bousser, 
& Drutel 
First advocated the use of the FEV1/FVC ratio. 
1951 Gaensler Analysis of the ventilation defect by timed vital capacity 
measurements. 
1955 Leuallen & Fowler Contributed the maximum mid-expiratory flow test. 
1957 Gandevia & Hugh-
Jones 
Published widely accepted terminology for pulmonary 
physiology. 
1958 Hyatt, Schilder, & 
Fry 
The expiratory flow-volume curve was introduced. 
1963 American College 
of Chest Physicians 
(ACCP) 
Modification of the terminology of dynamic lung 
volumes. 
1975 ACCP & American 
Thoracic Society 
Published a broad exposition on pulmonary 
nomenclature. 
(Adapted from Morris, J. F. (1976). Spirometry in the evaluation of pulmonary function 
(Medical Progress) Western Journal of Medicine, Volume 125, 110-118.) 
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2.2 Spirometry and the Respiratory System 
As described previously, spirometry is considered a medical screening test that 
helps evaluate lung function in individuals.  The lungs are part of the respiratory system 
which provides essential oxygen to all parts of the body as well as enabling the body to 
get rid of carbon dioxide.  The amount and delivery of oxygen needed for human cells to 
function properly is a delicate balance and important for overall health.  Lung 
morphology is determined by three major constraints: limited volume allocated to the 
structure, a need to protect the delicate gas exchange airways, and the large surface area 
needed for air-blood oxygen and carbon dioxide exchange (Miguel, 2012).  
The respiratory system is made up of organs and tissues that help an individual 
breathe, with the main parts of this system being the airways, the lungs, and linked blood 
vessels, and the muscles that enable breathing (National Heart, Lung, and Blood Institute, 
2012a). The airways that deliver vital oxygen-rich air to the lungs include the nose, 
mouth, larynx, trachea, and bronchial tree.  These same airways also carry out carbon 
dioxide which is a waste product of cellular respiration.  The oxygen that is transported 
through the respiratory system is ultimately transferred to the bloodstream at the alveoli 
located at the end of the bronchial tree.  It is estimated that an adult has approximately 
three hundred million alveoli with a surface area for gas exchange of about seventy-five 
square meters, which are perfused by more than two thousand kilometers of capillaries 
(Miguel, 2012).  Figure 2 presents a basic diagram of the respiratory system, airways, and 
gas exchange between the capillaries and alveoli. 
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Figure 2: Diagram of the Respiratory System.  (Source: National Heart Lung and Blood Institute, 
http://www.nhlbi.nih.gov/health/health-topics/topics/hlw/system.html, accessed 2012) 
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 When an individual breathes, air is moving in and out of the lung which is 
referred to as ventilation.  Muscles located near the lungs allow this process to happen by 
expanding and contracting the lungs.  Muscles used in this process include the 
diaphragm, intercostal muscles, abdominal muscles, and muscles in the neck and 
collarbone area.   
The movement of air into the lung is an active process called inspiration.  The 
movement of air out of the lung is a passive process call expiration and involves elastic 
recoil which returns the lung to its normal size.  Pulmonary compliance (stiffness) can 
affect elastic recoil by influencing the amount of pressure needed to increase or decrease 
the volume of the lung.  Airflow resistance can also negatively affect lung volumes due to 
the difficulty of air passing through the airways.  The responses of the lung to toxicants 
may be divided into the following general categories (Menzel & McClelln, 1980): 
• Irritation of the air passages, which results in constriction of the airways.  Edema 
often occurs and secondary infection frequently compounds the damage 
• Damage to the cells lining the airways, which results in necrosis, increased 
permeability, and edema 
• Production of fibrosis, which may become massive and cause obliteration of the 
respiratory capacity of the lung. Local fibrosis of the pleura also occurs, 
restricting the movement of the lung and producing pain through the irritation of 
pleural surfaces 
• Constriction of the airways through allergic responses 
• Oncogenesis leading to primary lung tumors 
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The above categories of pulmonary response to toxicants can affect pulmonary 
function by altering normal lung volumes.  Table 2 presents a number of different lung 
volumes accompanied by a brief description.  A spirometer can measure most lung 
volumes with the exceptions being total lung capacity, functional capacity, and residual 
volume. 
Table 2: Lung Volumes 
Tidal Volume 
The volume of gas which is inhaled or exhaled during the course of a normal resting 
breath. 
Residual Volume 
The volume of gas that remains in the lungs after a maximal forced expiration. 
Inspiratory Reserve Volume 
The volume of gas that can be further inhaled after the end of a normal tidal inhalation. 
Expiratory Reserve Volume 
The volume of gas that can be exhaled from the resting end-expiratory level. 
Capacity 
The sum of one of more lung volumes. 
Vital Capacity 
The volume of gas inhaled when a maximal expiration is followed immediately by a 
maximal inspiration. 
Functional Residual Capacity 
The volume of gas that remains in the lungs after a normal tidal expiration. 
(Adapted from Physics, Pharmacology and Physiology for Anesthetists, 2008) 
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 Airborne contaminants in the form of gases, liquids, or solids have the potential to 
harm the lungs if inhaled and ultimately decrease pulmonary function.  NIOSH (1977) 
recognizes the importance of the inhalation route in occupational settings and states: 
 Some of the highly reactive industrial gases and vapors of low solubility 
can produce an immediate irritation and inflammation of the respiratory tract and 
pulmonary edema.  Prolonged or continued exposure to these gases and vapors 
may lead to chronic inflammatory or neoplastic changes or to fibrosis of the lung.  
Fibrosis, as well as granulomatosis and malignancy, also may be produced by 
certain insoluble and relatively inert fibrous and nonfibrous solid particulates 
found in industry.  Indeed, it is now thought that one of the prerequisites for 
particulate-induced bronchogenic carcinoma may be the insolubility of the 
particulate in the fluids and tissues of the respiratory tract, which thereby allows 
requisite residence time in the lung for tumor induction. 
The fact that the surface area of the lungs is so large, potential for occupational 
lung disease is a concern if airborne hazards of the workplace are not controlled through 
appropriate measures.  Consider that many occupations require physical exertion which 
can increase the amount of air inhaled.  For example, a person at rest inhales 
approximately six liters of air a minute compared to approximately seventy-five liters per 
minute during heavy exercise (NIOSH, 2003).  
 An airborne contaminant can affect pulmonary function if they pass through the 
respiratory system and reach the alveoli.  Menzel & McClellan (1980) state the following 
about the toxic responses of the respiratory system: 
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 The deposition and retention of inhaled gases and aerosols are influenced 
by many anatomic features of the respiratory tract, including lung volume, 
alveolar surface area, and structure and spatial relationships of conducting 
airways into alveoli.  Distribution of deposited material as a function of time, in 
combination with the location of the over forty cell types identified in the 
respiratory tract, determines the cells at risk for any inhaled material. 
 Gases, fumes, and vapors all have the potential to affect lung function.  This 
group includes irritant acid gases, very soluble gases, and gases and vapors of low water 
solubility but high fat solubility.  Irritant acid gases for the most part are fast acting 
chemicals that affect the upper airway passages.  Very soluble gases typically deposit in 
the upper or proximal airways and if the dose is sufficient, emphysema and fibrosis may 
develop.  Gases and vapors of low water solubility and high fat solubility are more likely 
to reach the distal airways and ultimately the blood. 
The deposition, retention, distribution, and ultimate health effects of particulates 
differs from that of gases, fumes and vapors.  The aerodynamic properties of particles and 
fibers determine how far they can travel into the body and ultimately determine where 
they are deposited in the respiratory system.  Particles up to one hundred microns can be 
inhaled though the nose, however particles larger than fifty microns typically do not 
remain airborne long enough to be inhaled.  If they are inhaled, they become trapped in 
the nasal passage.  Particles less than ten microns are considered to be respirable and 
have the potential to reach deep into the lungs.  Particles one to five microns in size are 
more likely to deposit in the trachea and bronchi while particles 0.01 to one micron in 
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size are likely to reach the bronchioles, alveolar ducts, and alveoli.  Figure 3 presents size 
ranges for various particles. 
Figure 3: Particle Size Distribution Graph in Microns.  (Source: National Institute of 
Environmental Health Sciences, 
www.niehs.nih.gov/health/assets/docs_a_e/ehp_student_edition_lesson_particles_size_m
akes_all_the_difference.pdf, accessed 2012) 
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2.3 Spirometry Testing and Results 
Spirometry is conducted using a spirometer, which measures the quantity of air a 
person inhales or exhales and the rate at which the air is moved in and out of the lungs.  
The process of obtaining spirometric volumes is relatively easy and is explained by 
Garay (2007): 
The subject is instructed to breathe normally with a resting tidal pattern as 
the volume is being recorded.  Next, the subject inspires maximally, then exhales 
as completely as possible with a slow, continuous, smooth exhalation and returns 
to tidal breathing.  The result is the slow vital capacity (SVC).  FVC is measured 
with virtually the same maneuver, but the patient is instructed to exert maximal 
forced expiratory effort. 
Spirograms are graphic representations of the information obtained from the test.  
Spirometers can measure volume through the amount of air exhaled or inhaled within a 
certain time or they can measure flow by determining how fast the air flows in or out as 
the volume of air inhaled or exhaled increases.  Figure 4 presents a flow-volume loop and 
a volume-time curve. 
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Figure 4: Normal Volume Time Curve and Flow Volume Curve.  (Source: NIOSH 
Spirometry Training Guide, 2003) 
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Spirometry results indicate the presence of lung abnormalities which include 
obstructive patterns, restrictive patterns, or a combination of both.  In obstructive 
diseases, less air flows in and out of the airways because of one or more of the following: 
airways and air sacs lose their elastic quality; walls between many of the air sacs are 
destroyed; walls of the airways become thick and inflamed; airways make more mucus 
than usual, which can clog them (National Heart Lung and Blood Institute, 2012b).  
Restrictive disease is a condition marked most obviously by a reduction in total lung 
capacity caused by a pulmonary deficit, such as pulmonary fibrosis (abnormally stiff, 
non-compliant lungs) (John Hopkins University School of Medicine, 2012).  Table 3 
presents an overview of occupational obstructive and restrictive lung diseases. 
Table 3: Overview of Occupational Lung Disease 
Pulmonary Diseases that Show 
Obstructive Patterns 
Pulmonary Diseases that Show 
Restrictive Patterns 
Occupational Asthma Pneumoconioses 
Reactive Airways Dysfunction Syndrome Hypersensitivity Pneumonitis 
Emphysema Granulomatous Disease 
Chronic Bronchitis Other Health Conditions 
(Adapted from NIOSH Spirometry Training Guide, 2003) 
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Chapter 3 
Health Surveillance 
The purpose of surveillance is to target work-related diseases and injuries so that 
prevention can occur (Millar, 1986).  This chapter presents a number of studies that use 
surveillance data to determine the health status of various groups of individuals.  In 
addition, this chapter will look specifically at pulmonary function data and its utility in 
comparative analysis. 
3.1 Disease Surveillance 
3.1.1 National Health and Nutrition Examination Survey 
National Health and Nutrition Examination Survey III (NHANES III) data has 
been successfully used as a baseline population for health surveillance.  NHANES is a 
program of studies designed to assess the health and nutritional status of adults and 
children in the United States (Center for Disease Control and Prevention, 2012).  The 
South Carolina Department of Health and Environmental Control (1999) recognized that 
NHANES III data provides the most recent and most accurate estimate of the prevalence 
of overweight and obesity in the United States and that when these data are applied to the 
adult population in South Carolina, it provides useful estimates of the number of 
overweight and obese individuals in the State.  This is just one example of how NHANES 
III data can be used to determine if a population level abnormality exists with a specific 
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group of individuals.  The following studies provide further examples of the use of the 
NHANES data set in comparative analyses. 
McEvoy et al. (2005) conducted a study to determine the prevalence of metabolic 
syndrome (a risk factor for cardiovascular disease) in United States patients with 
schizophrenia.  They used baseline data from the Clinical Antipsychotic Trials of 
Intervention Effectiveness (CATIE) Schizophrenic Trial.  Comparative analyses were 
performed using a randomly selected sample from NHANES III matched 1:1 on basis of 
age, gender, and race/ethnicity.  In a logistic regression model with age, race, and 
ethnicity as covariates, CATIE males and females were more likely to have metabolic 
syndrome than the NHANES matched samples.  The conclusion of the study indicated 
that metabolic syndrome is highly prevalent in United States schizophrenic patients and is 
a source of cardiovascular risk.  They suggest that clinical attention be given to 
monitoring for metabolic syndrome and minimizing metabolic risks associated with 
antipsychotic treatment. 
Lamberti et al. (2006) conducted a study to compare the prevalence of the 
metabolic syndrome among outpatients with schizophrenia and schizoaffective disorder 
receiving clozapine with a matched group from NHANES III.  Ninety-three outpatients 
were compared to a group of 2,701 individuals matched for age, body mass index, and 
race/ethnicity.  Logistic regression analyses were performed to determine if study 
variables were associated with the presence or absence of metabolic syndrome.  The 
results of the study found that the prevalence of the metabolic syndrome was significantly 
higher among clozapine patients than among the NHANES III comparison group.  This 
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research identified that regular monitoring may be especially critical for schizophrenic 
patients taking clozapine due to the high prevalence of metabolic abnormalities reported 
in this study and others. 
Herrington et al. (1998) conducted a comparative analysis to determine the 
efficacy of postmenopausal estrogen/progestin therapy for secondary prevention of 
coronary heart disease.  To conduct the analysis, they compared the baseline 
cardiovascular risk factor data from the Heart and Estrogen/Progestin Replacement Study 
(HERS) cohort with similar data from women presumed to have coronary heart disease 
from NHANES III.  Age, race, and cardiovascular disease risk factors were compared in 
the 2,763 postmenopausal women younger than eighty years old, with a uterus, and with 
documented cardiovascular disease in HERS to 145 similarly aged women with clinical 
or electrocardiographic evidence of coronary heart disease from NHANES III.  The 
results indicated that the HERS cohort had fewer cardiovascular risk factors than women 
with myocardial infarction or angina in NHANES III.  It was determined that due to the 
number of women with diabetes and hypertriglyceridemia in the NHANES III group, 
these results emphasized the importance of testing strategies for secondary prevention of 
coronary heart disease in this high risk subgroup. 
Dickerson et al. (2006) conducted a study to examine the distribution and 
correlates of body mass index among individuals with serious mental illness.  A 
comparison of body mass index was made between 169 out-patients receiving 
community-based psychiatric care and 2,404 matched individuals from the NHANES III 
data set.  The distribution of body mass index in individuals with serious mental illness 
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differed significantly form the NHANES III comparison group.  The results showed that 
fifty percent of women and forty-one percent of men in the psychiatric sample were 
obese compared with twenty-seven percent and twenty percent in the NHANES III 
group.  In addition, the higher body mass index linked to individuals with serious mental 
illness was associated with current hypertension, diabetes, a wish to weigh less, and 
reduced health-related functioning. 
Goff et al. (2005) conducted a study to compare ten-year cardiac risk estimates in 
schizophrenia patients from the CATIE study to matched controls.  Ten-year risk for 
coronary heart disease was calculated for 689 out-patients with a diagnosis of 
schizophrenia who participated in the CATIE study.  They were compared to 687 
NHANES III subjects matched for age, race, and gender.  Ten-year coronary heart 
disease was significantly higher in male and female schizophrenia patients compared to 
the NHANES III control population.  The results of this research were consistent with 
other studies which find that schizophrenia patients in the CATIE study at baseline have a 
significantly higher risk for coronary heart disease compared to matched controls.  This 
holds true even after controlling for body mass index.  The authors conclude that based 
upon the findings of the study that cardiac risk factors should be evaluated and monitored 
by clinicians and behavioral or pharmacological interventions should be implemented as 
indicated. 
Streeten et al. (2004) conducted a study to compare hip fracture incidence and 
bone mineral density in Older Order Amish to the general population.  To assess the bone 
health of the Older Order Amish population, bone mineral density data was selected from 
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among participants of the Amish Family Osteoporosis Study and compared to a United 
States non-Amish white population obtained from NHANES III.  Statistical significance 
between the groups was assessed by estimating the variance of the pooled difference in 
bone mineral density across age groups.  Results indicated that the Older Order Amish 
had a higher mean bone mineral density that was significant in women but not in men 
compared to the NHANES III population.  The authors concluded that based upon the 
findings of the study that additional research of lifestyle and/or genetic differences 
between Amish and the general population may provide insights into etiologic factors 
influencing hip fracture risk. 
Castorina et al. (2010) conducted a study to compare current-use pesticide and 
other toxicant urinary metabolite levels among pregnant women in the Center for the 
Health Assessment of Mothers and Children of Salinas (CHAMACOS) cohort to the 
general population.  They measured thirty-four metabolites of current-use pesticides and 
other precursor compounds in urine samples collected twice a day from 538 women 
living in the Salinas Valley of California.  Metabolite concentrations from the 
CHAMACOS cohort were compared with United States national reference data for 342 
pregnant women sampled by NHANES to determine the impact of the women’s regional 
environment.  The results of the study found that the 95th percentile values of six of the 
most commonly detected compounds were significantly higher among the CHAMACOS 
women compared to the NHANES group after controlling for age, race, socioeconomic 
status, and smoking.  The authors conclude that findings indicate that the CHAMACOS 
cohort has an additional burden of precursor pesticide exposure compared to the general 
population, which is possibly due to living and/or working in an agricultural area. 
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Xu et al. (2009) conducted a study to compare the prevalence of chronic kidney 
disease among native Chinese and American ethnicities.  In 2006, a stratified multistage 
clustered screening for chronic kidney disease was conducted in Beijing and resulted in 
13,626 participants.  The data collected from the screening was compared to NHANES 
data which included 9,006 American whites, 3,447 African Americans, and 4,626 
Hispanics.  The results indicated that when compared to NHANES data, Chinese had a 
lower prevalence of adjusted albuminuria as well as the lowest risk of albuminuria when 
diagnosed with diabetes.  Chronic renal insufficiency among Chinese when diagnosed 
with diabetes or hypertension was found to be lower when compared to African 
Americans but not significantly different than whites or Hispanics.  The authors 
concluded that the prevalence of chronic kidney disease was significantly different 
between native Chinese and American ethnicities. 
Brar et al. (2007) conducted a study to compare diabetes mellitus prevalence and 
its predictors in antiretroviral-naïve HIV-infected patients compared to the general 
population.  A cross-sectional analysis of 2,565 participants enrolled in three Terry Beirn 
Community Programs for Clinical Research on AIDS (CPCRA) clinical trials were 
compared to 6,585 adults from the NHANES cohort for the years 2001 through 2002.  
The results indicated that the prevalence of diabetes mellitus was significantly lower 
among CPCRA subjects compared to NHANES subjects.  However, after adjusting for 
age, race/ethnicity, and body mass index, there was no significant difference in the 
prevalence of diabetes mellitus between CPCRA subjects and NHANES subjects. 
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Burger et al. (2011) conducted a study to investigate the correlation between body 
mass index and pulmonary artery systolic pressure in patients enrolled in the Registry to 
Evaluate Early and Long-term Pulmonary Arterial Hypertension (PAH) Disease 
Management (REVEAL) to NHANES subjects.  The two groups were matched for age 
and gender with ultimate goal of determining whether obesity is linked with PAH.  The 
results indicated that there was no significant difference in mean body mass index for 
patients with PAH compared to the NHANES control group.  However, results did find 
that there were higher percentages of obese and underweight patients in REVEAL.  The 
authors concluded that further research is needed to determine the reason for increased 
obesity in idiopathic PAH. 
Dickerson et al. (2004) conducted a study to compare sexual reproductive 
behaviors among persons with mental illness to the general population.  The study sample 
consisted of 191 men and women with schizophrenia or a mood disorder recruited from 
two outpatient psychiatric centers.  The comparison group was selected from the 
NHANES III data set and for age and race.  The responses from the two groups were 
compared using regression analysis for each outcome variable by gender.  The findings of 
this study suggest gender differences in sexual behaviors among people with mental 
illness.  Women with mental illness reported having more partners than the NHANES III 
comparison group.  In addition, women with mental illness had fewer live births and were 
less likely to get pregnant compared to the NHANES III comparison group.  The authors 
conclude that as a result of the findings, there is a need to prevent sexually transmitted 
diseases and victimization of women with mental illness and that physicians need to pay 
special attention to the sexual and reproductive health of this group. 
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Sarma et al. (2009) conducted a study to determine the urinary incontinence 
among women with type 1 diabetes to a population based sample of women with normal 
glucose.  A group of 550 women enrolled in the Epidemiology of Diabetes Interventions 
and Complications (EDIC) study were compared to 383 women with complete 
incontinence information from the NHANES 2001 to 2002 sample.  Women from the 
EDIC study that had type 1 diabetes had a two-fold greater prevalence of weekly or 
greater urge incontinence compared to the NHANES III comparison group.  Based on the 
findings of this study, the authors concluded that physicians treating women with type 1 
diabetes should look for incontinence because it is often unrecognized and therefore 
untreated in women with diabetes. 
Abalkhail and Shawky (2002) conducted a study to compare the body mass index, 
triceps skin fold thickness and mid-arm muscle circumference in Saudi adolescents to a 
recognized reference population.  Data was collected from 2,737 Saudi adolescents 
selected from forty-two boys’ and forty-two girls’ schools in Jeddah and compared with 
corresponding values from NHANES I.  The results of the study showed that the 85th 
percentile and 95th percentile for body mass index and triceps skin fold thickness were 
higher for Saudi adolescents compared to the NHANES I comparison group.  In addition, 
Saudi adolescents had lower mid-arm muscle circumference at the 90th percentile and 95th 
percentile compared to the NHANES I reference population curves.  The authors 
concluded that Saudi adolescents show increased weight and obesity along with increased 
body fat and decreased body muscle compared to the NHANES I comparison group.  
They suggest that public health interventions are needed to improve quality of food, 
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encourage physical activity, and change the perception of appropriate body stature in 
Saudi Arabia. 
Huang et al. (2004) conducted a study to compare 1-hydroxypyrene exposure in 
the United States population with that in occupational exposure studies.  Data was 
analyzed for fourteen monohydroxy polycyclic aromatic hydrocarbons from urine 
samples collected as part of NHANES.  Reference range values were calculated for these 
metabolites in the United States population.  As part of the analysis, it was determined 
that 1-hydroxypyrene was detected in more than ninety-nine percent of the samples with 
an overall geometric mean concentration of 79.8 nanograms per liters in the United States 
population.  This data was used to compare the reference range of urinary 1-
hydroxypyrene levels in the United States population with levels reported from various 
occupations by other researchers.  Comparative analysis indicated that at some 
occupations, such as coke oven plants and carbon electrode plants, workers’ urinary 1-
hydroxypyrene concentration levels could be a few hundred times higher than the general 
United States population.  The authors of this study concluded that additional research is 
needed that directly correlates urinary 1-hydroxypyrene with health effects such as cancer 
risk to gain a better understanding of occupational polycyclic aromatic hydrocarbon 
exposure and determination of biological limit values. 
Comparative research provides an opportunity to investigate health data across 
different populations.  This type of research is important so that evaluations can be made 
between different groups to identify populations at high risk and identify new or 
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emerging health concerns. The studies referenced in this section show the utility and 
strength of using NHANES data in comparative research and analysis. 
3.1.2 Occupational Respiratory Disease Surveillance 
In terms of occupational respiratory disease surveillance, NIOSH and the Mine 
Safety and Health Administration have implemented the Enhanced Coal Workers’ Health 
Surveillance Program (ECWHSP).  According to NIOSH (2012d): 
Coal mining-related respiratory diseases can affect the gas exchanging 
tissues of the lungs.  These lung tissues remove carbon dioxide and take up 
oxygen.  The diseases can also affect the lung passages that carry air back and 
forth during breathing.  The passages are called airways.  Depending on what is in 
the coal mine dust that is inhaled and the part of the lung that is affected, coal 
miners may develop several different types of respiratory diseases. 
This program was developed due to the observed onset of advanced pneumoconiosis in 
younger coal miners along with regional clustering of rapidly progressive cases.  
Pneumoconiosis is a disease of the lung and refers to the scaring of the tissue between the 
air sacs. The two primary pneumoconioses related to coal mining are coal workers’ 
pneumoconiosis (CWP) and silicosis: 
• CWP, commonly called Black Lung, is type of pneumoconiosis caused by 
inhaling respirable coal mine dust.  Chest x-rays can show shadows in the lungs 
called opacities. In severe cases, there are more opacities in a given area of the 
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lung.  The most severe type of CWP is called progressive massive fibrosis (PMF).  
In PMF, the opacities come together and become large (NIOSH, 2012d). 
• Silicosis is a type of pneumoconiosis caused by inhaling respirable crystalline 
silica.  Quartz is a type of crystalline silica that causes silicosis in coal miners 
because it is a major component of rocks.  Silicosis causes x-ray changes similar 
to CWP; and it is especially seen in coal miners who are exposed to rock dust, 
such as roof bolters in underground mines and drillers in surface mines (NIOSH 
2012d). 
Surveillance of coal miners includes surveys, health questionnaires, work 
histories, spirometry testing, radiographic examinations, and other pertinent health 
information. This data is collected by specially trained personnel using a mobile 
examination unit.  Figure 5 presents a poster promoting the participation in the Coal 
Workers’ Health Surveillance Program. 
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Figure 5: Black Lung Poster.  (Source: DHHS (NIOSH) Publication Number 2003-123 (2003))  
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In addition to the to the ECWHSP, NIOSH has a separate projected called ‘Dust 
Control Technology for Black Lung Hot Spots’ which collects coal mineralogy, mining 
conditions, respirable dust and silica exposure concentrations, mining and dust control 
strategies, and other pertinent data in regions with disease clusters.  The results of these 
NIOSH activities are intended to facilitate preventive actions, through the derivation of 
representative current estimates of the burden, distribution, and determinants of 
occupational lung disease in relation to coal mining in the United States (NIOSH, 2012e). 
3.1.3 Pulmonary Function Surveillance Data 
NIOSH (2003) recommends that employment settings where workers use 
respirators or are potentially exposed to airborne toxicants should have a respiratory 
surveillance program which should include the use of spirometry.  Such programs 
generate pulmonary function data that can be used to conduct a population level analysis.  
The potential outcome of such research includes the prevention, early detection, and 
treatment of occupational diseases.  This leads to a healthier workforce, which in turn can 
lessen the unnecessary burdens associated with worker’s compensation claims, litigation 
fees, insurance premiums, and medical bills. 
Pulmonary function testing is particularly well suited for occupational 
surveillance with the availability of the NHANES III Raw Spirometry data set. NHANES 
III was conducted from 1988 to 1994, and is comprised of a random sample of the United 
States population living in households.  In terms of spirometry data, NHANES III 
improved upon data collection and data quality.  Hankinson et al. (1999) describe such 
improvements: 
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One significant aspect of NHANES III was the use of equipment and 
procedures that met the 1987 American Thoracic Society’s spirometry 
recommendations, and featured automated quality assessment during test 
performance.  To maintain the highest level of technician performance, a quality 
control center continuously reviewed the data and provided quality control reports 
and follow-up training as appropriate.  In 1994, as NHANES III was completing 
data collection, the American Thoracic Society revised its 1987 spirometry 
recommendations, which included changes in both the extrapolated volume and 
the reproducibility criteria.  In addition the NHANES III spirometry protocol 
called for each participant to perform a minimum of five maneuvers, which 
differed from the three acceptable maneuvers recommended by the American 
Thoracic Society.  To make findings from NHANES III useful to future 
investigations utilizing the 1994 American Thoracic Society’s recommendations, 
the raw data were also reanalyzed to follow the 1994 American Thoracic 
Society’s recommendations, and the impact of using a minimum of five versus 
three maneuvers was investigated. 
This data allows for population level analysis of worker spirometry data to be compared 
to a standard population, adjusted for age, height, tobacco smoking, and other factors that 
impact pulmonary function not related to the occupational environment.  
Spirometric interpretation utilizes reference equations as threshold criteria for the 
diagnosis of lung disease.  Many studies have published lung function values, so there 
has been considerable debate in the past regarding the applicability of the various 
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reference equations used for analysis.  Pellegrino et al. (2005) determined that in the 
United States, ethnically appropriate NHANES III reference equations are recommended 
for those aged eight to eighty years.  Furthermore, Collen et al. (2008) has conducted 
research on discordance in spirometric interpretations using three commonly used 
reference equations versus NHANES III and found that: 
Although our study was not designed to identify the optimal reference 
equation for this population, we believe the NHANES III equations are the best 
available to date.  The NHANES III equations are based on a sample size that was 
ten-fold greater than those in any of the prior studies and included a 
heterogeneous population that was enrolled from 1988 to 1994.  These equations 
are less subject to cohort effect in comparison to those derived by the Crapo, 
Morris, and Knudson studies, which enrolled patients in earlier decades. 
 The NHANES III Raw Spirometry data contains over 15,000 individual 
spirograms matched to standard NHANES demographic and survey data.  Once 
compiled, mandatory pulmonary function data from exposed workers can be reliably 
analyzed for comparison to NHANES III data to determine if a population level 
abnormality exists within a specific occupation.  
The objective of this research is to compile raw data from occupational health 
monitoring reports into a coherent database to determine the utility and feasibility of this 
data as an instrument for evaluating potential health effects associated with working in 
various occupational sectors.  The results of this research can be used to develop and 
implement safe work practices that reduce chemical exposure for workers in the State of 
42#
#
Florida.  The hypothesis that was tested was: Pulmonary function is impaired among 
workers of selected industries exposed to various toxicants.  Three principle occupational 
sectors represented in the data source include boat manufacturers, electric utility workers, 
and first responders.  Previous findings indicate that these occupational sectors have 
unique exposures that put them at risk for specific pulmonary diseases. 
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Chapter 4 
Literature Review 
Various occupational sectors including the public sector, general industry, 
construction, and maritime have unique exposures, which if uncontrolled, may lead to 
adverse health effects.  While regulations exist to protect workers from these exposures, 
it is necessary to monitor certain health outcomes to ensure these exposure controls are 
effective for each individual.  Analysis of this health outcome data on the population 
level may provide insight into health effects that occur in occupational sectors despite the 
presence of protective regulatory measures.  This research focuses on boat manufacturers, 
electric utility workers, and first responders.  Previous findings indicate that these 
occupational sectors have an increased risk for pulmonary function impairment to occur 
among workers because of potential exposure to airborne hazards. 
It should be noted that uncertainty is inherent in pulmonary function 
measurements.  However, the objective of this research is to collect available pulmonary 
function data and use this information to evaluate potential health effects associated with 
working in various occupational sectors.  The articles presented as part of the literature 
review were included to provide some justification to investigate and identify 
occupational sectors that may be susceptible to pulmonary function impairment with the 
ultimate goal of minimizing exposure of workers through hazard control. 
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4.1 Boat Manufacturing 
Manufacturing is an important part of Florida’s growing economy.  In 2011, 
Florida was the home to nearly eighteen thousand manufacturing facilities that employed 
close to 312,000 people with a total payroll of more than sixteen million dollars 
(eFlorida, 2012).  The National Marine Manufacturers Association (NMMA) reported 
that in 2008, there were 242 active boat builders in Florida (NMMA, 2012). The United 
States Environmental Protection Agency (USEPA) (2008) states: 
Several types of boats are manufactured in the United States, including 
sailboats, powerboats, yachts, personal watercraft, and small miscellaneous boats 
such as kayaks and canoes.  These boats are manufactured from a variety of 
materials, including, but not limited to, fiber glass (also known as fiber reinforced 
plastic or FRP), aluminum, rotationally molded (rotomolded) polyethylene, and 
wood.  Fiberglass is the most common material used in boat manufacturing.   
During the manufacturing of fiberglass boats, there are a number of sources of 
volatile organic compound emissions.  The USEPA (2008) reports: 
 Styrene and methyl methacrylate are the primary volatile organic 
compounds emitted from fiberglass boat manufacturing materials.  The resins 
contain styrene and the gel coats contain both compounds. Styrene and methyl 
methacrylate are monomers.  A monomer is a volatile organic compound that 
partially combines itself, or other similar compounds, by a cross-linking reaction 
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to become a part of the cured resin.  A fraction of each monomer evaporates 
during resin and gel coat application and curing. 
In the boat manufacturing industry, styrene is widely used in the production of 
fiberglass based hulls.  In 1995, Florida had thirty-nine boat manufacturing facilities that 
reported styrene emissions to the Toxic Release Inventory database (USEPA, 2001).  
Styrene is used as an intermediate for chemical synthesis resins and in the manufacture of 
polymeric plastics (Baselt, 2002).  Styrene is a respiratory irritant, and acute exposures of 
three hundred to seven hundred parts per million result in nasal and pulmonary irritation 
and inflammation (Carpenter, 1944; Stewart, 1968; NIOSH, 1983).  Obstructive 
pulmonary disorders have been observed in chronically exposed workers, though 
exposures controlled at the OSHA permissible exposure limit of one hundred parts per 
million are thought to prevent chronic pulmonary impairment (Chmielewski & Renke, 
1975).  However, not all respiratory system studies are conclusive.  For example, Stewart 
et al. (1968) studied the effects of styrene on pulmonary function and found that FEV1 
was significantly decreased in only twenty percent of a group of workers exposed to 
styrene.   
While some studies are inconclusive regarding long term styrene inhalation and 
occupational asthma due to additional chemicals in the environment to which the workers 
may have been exposed, styrene has been reported as a cause of occupational asthma in a 
few case reports.  Oner et al. (2004) conducted a study to investigate the risk for 
occupational asthma in relation to exposure to styrene in a large number of workers.  He 
used pulmonary function testing as a measure to associate styrene exposure and 
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occupational asthma.  The findings of the study were not conclusive about the causative 
role of styrene in occupational asthma but concluded that further research in this area 
should be conducted.   
Current research by Sati et al. (2011) evaluated pulmonary function in workers 
exposed to styrene in a plastic factory and found a statistically significant reduction (p-
value less than 0.05) in most of the lung volumes, capacities (FVC, FEV1, Vital Capacity 
(VC), Expiratory Reserve Volume (ERV), Inspiratory Reserve Volume (IRV), and 
Inspiratory Capacity (IC)) and flow rates (Peak Expiratory Flow Rate (PEFR), Maximum 
Expiratory Flow (MEF) (75%), and Maximum Voluntary Ventilation (MVV)) in the 
study group (workers) as compared to controls.   
In the boat manufacturing industry, methyl methacrylate is also used in the 
production of fiberglass based hulls.  Methyl methacrylate has an odor threshold of less 
than 0.4 parts per million and is immediately dangerous to life and health at a 
concentration of one thousand parts per million (Ungers, 2007).  A number of studies 
have shown occupational asthma associated with exposures to methacrylates or more 
specifically methyl methacrylate in an occupational setting.  Occupational asthma is a 
disease characterized by variable airflow limitation and/or airway hyper responsiveness 
due to causes and conditions attributable to a particular occupational environment and not 
to stimuli encountered outside the workplace (Bernstein, 1993). 
Piirila et al. (1998) conducted a study of occupational respiratory hypersensitivity 
caused by preparations containing acrylates in dental personnel.  The objective of the 
study was to report the cases of acrylates induced respiratory hypersensitivity in dental 
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personnel over a six year period.  The results of the study found that twelve cases of 
respiratory hypersensitivity caused by acrylates were diagnosed in dental personnel in 
Finland from 1992 to 1997.  Nine cases of occupational asthma were verified according 
to challenge tests with dental acrylate compounds (acrylates, methacrylates, and epoxy 
acrylates).  Peak expiratory flow follow-up showed an occupational effect in the eight 
examined patients with diagnosed asthma. 
In 2002, Piirila et al. published a follow-up study regarding occupational 
respiratory hypersensitivity in dental personnel.  The objective of the study was to 
evaluate the causes of respiratory hypersensitivity in dental personnel based upon 
statistics provided by the Finnish Register of Occupational Diseases (1975-1998) and the 
patient material of the Finnish Institute of Occupational Health (1990-1998).  Results of 
the study found that a total of sixty-four cases of occupational respiratory diseases were 
diagnosed in dental personnel during 1975 to 1998.  Twenty-eight of the reported cases 
were of occupational asthma with eighteen of those caused by methacrylates.  The study 
showed an increasing frequency of respiratory hypersensitivity among dental personnel 
with methacrylates being an important cause of the condition. 
Marez et al. (1993) investigated bronchial symptoms and respiratory function in 
workers exposed to methyl methacrylate.  The study showed that spirometric values at 
the start of the work shift were similar in the control group and study group, but a mild 
airways obstruction appeared during the work shift.  The maximum expiratory flow when 
50 percent of the forced vital capacity remained to be exhaled (MEF50) and the ratio of 
MEF50 to maximal expiratory flow decreased significantly during the work shift among 
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exposed workers compared to the controls.  It should be noted that the differences 
remained the same after adjusting for smoking habits. The results of this study support 
the hypothesis that methyl methacrylate can cause pulmonary function disorders and 
airway obstruction among exposed workers. 
Pickering et al. (1986) evaluated occupational asthma due to methyl methacrylate 
in an orthopeadic theatre sister. A fifty-six year old theatre sister who presented with 
asthma had worked in an orthopaedic operating theatre for eleven years in which the 
mixing process used to make dental implants created a brief period of a high 
concentration of methyl methacrylate in the air. Her asthmatic symptoms consistently 
resolved when she was absent from work for a period of time.  Testing was conducted 
and results found that a late asthmatic reaction occurred in the patient after challenge with 
methyl methacrylate which resulted in a maximal fall in FEV1 of twenty-five percent.  
The authors concluded that brief but repeated exposure to high peak concentrations of 
methyl methacrylate which is a known pulmonary sensitizer is undesirable and that the 
use of a fume cupboard for the initial mixing process is strongly recommended. 
Lozewicz et al. (1985) evaluated occupational asthma due to methyl methacrylate 
and cyanoacrylates in seven patients.  One of two patients exposed to methyl 
methacrylate had an asthmatic reaction. The patient was a dental assistant that produced 
paste by mixing polymethyl methacrylate powder with monomethyl methacrylate liquid 
for the production of dental prosthetic trays.  Inhalation testing included modeling his 
exposure at work to methyl methacrylate for twenty minutes, which provoked a fall in 
PEF of twenty-four percent. The test was repeated two weeks later and produced similar 
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immediate asthmatic reaction, which also resolved over a two-hour period.  The author’s 
conclusion included substitution of less volatile, longer chain alkl cyanoacrylate 
homologues as well as the use of appropriate ventilation when using acrylates. 
Jerdrychowski et al. (1982) assessed the biological effect of styrene and methyl 
methacrylate on the respiratory system in an industrial population.  Four hundred and 
fifty four males from the exposed group and 683 workers from the control were evaluated 
by standardized interviews on chest symptoms and lung function testing. The frequency 
of lung obstruction appeared to be more than twice as high among the exposed group 
compared to the control group.  The exposed group showed much poorer lung function as 
well when compared to the control group.  The overall results of the study showed that 
the harmful effect of styrene and methyl methacrylate on lung function was strong 
despite the rather low prevalence of chronic chest symptoms.  The results of the study 
further support the need for epidemiological evidence aimed at explaining a cause-effect 
relationship between low-level concentrations of styrene and methyl methacrylate in the 
industrial environment and potential harmful effects.  
Due to the potential for occupational exposure to styrene and methyl methacrylate 
during the boat manufacturing process, the potential for pulmonary function impairment 
among workers exist.  Spirometry data provides an opportunity to perform occupational 
health surveillance and further determine the potential association between styrene 
exposure and pulmonary function impairment as well as develop safe work practices in 
this industry with the ultimate goal of reducing chemical exposure. 
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4.2 Utilities 
In Florida, fossil fuel power generation is used to provide electricity to sustain 
commercial, agricultural, and residential needs.  Operations involved in these power 
plants include coal handling, boiler-turbine operation, and routine maintenance.  Utility 
workers that perform these operations have the potential to be exposed to chemicals in 
the workplace that can affect pulmonary function.  For example, coal handling includes 
coal receiving, storage, and recovery for fueling the turbine generator units and leads to 
certain tasks which are associated with high coal dust air levels and require respiratory 
protection (Jackson, 1998).   
During boiler maintenance, cleaning, and repair, utility workers can be exposed to 
fossil fuel ash particles.  Hauser et al. (2001) conducted a two-year longitudinal study of 
lung function among 118 boilermakers and found that working at gas, oil, and coal-fired 
plants is associated with an annual loss in FEV1.   
Bridbord et al. (1979) identified a number of irritants, vesicants, and fibrogens 
within coal-fired power plants which included sulfur dioxide (SO2), SO2 reaction 
products, nitrogen oxide (NO), nitrogen dioxide (NO2), fly ash, aldehydes, coal dust, and 
asbestos.  Potential sources of these chemicals included boiler leaks, flue gas leaks, stack 
emissions, all stages of coal handling, and insulation material.  Over sixty-five percent of 
SO2 released to the air, or more than thirteen million tons per year, comes from electric 
utilities, especially those that burn coal (Scientific Committee on Occupational Exposure 
Limits, 2008).  NIOSH (1978) has identified SO2 as a respiratory irritant and indicates 
that studies have shown increased pulmonary resistance at various concentrations.   
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Asbestos is another airborne risk that electric utility workers encounter during 
routine maintenance.  Vathesatogkit et al. (2004) conducted a study related to asbestos 
exposure by using subjects recruited from Consolidated Edison, which is an electric 
utility located in New York City.  In regard to pulmonary function, the study concluded 
that in individuals with a history of asbestos exposure, the presence of asbestos bodies in 
BAL cells is associated with a higher prevalence of parenchymal abnormalities, 
respiratory symptoms, and a reduction in pulmonary function. 
Utility workers also have the potential to be exposed to polychlorinated biphenyl 
(PCB) when working with transformers and capacitors.  Warshaw et al. (1979) found a 
decrease in vital capacity in PCB-exposed workers in a capacitor manufacturing facility. 
This finding indicates the potential for compromise in pulmonary function after PCB 
exposure.  
Due to the potential for occupational exposure of electrical utility workers during 
fossil fuel power generation and routine maintenance to a variety of chemicals that may 
decrease pulmonary function, spirometry data provides an opportunity to perform 
occupational health surveillance and evaluate safe work practices in this industry with the 
ultimate goal of reducing chemical exposure. 
4.3 First Responders 
First responders are exposed to a variety of fumes, gases, and particulates during 
the course of their job.  They often disregard the risk of chemical exposure in order to 
attend to injured victims and/or contain the release.  Consider the first responders that 
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were on the scene after the collapse of the World Trade Center.  They encountered high 
levels of airborne pollutants and have since reported respiratory symptoms and developed 
pulmonary function abnormalities.  Banauch et al. (2006) found that World Trade 
Center–exposed workers experienced a substantial reduction in adjusted average FEV1 
during the year after 09/11/2001 and that this exposure-related FEV1 decrement equaled 
twelve years of aging-related FEV1 decline.   
First responders include fire fighters, police, and emergency medical personnel. 
All of theses occupations are physically demanding and challenging, with potential for 
exposing workers to toxic agents in a dynamic and uncontrolled environment.  For 
example, toxic chemicals emitted as a result of incomplete combustion and pyrolysis 
include hydrochloric acids, carbon monoxide, vinyl chloride, hydrogen sulfide, etc. 
(Becker, 1985).  These chemicals have the potential to cause pulmonary function 
impairment if exposures are not properly controlled.  Burgess et al. (2001) state:  
Occupational smoke exposure may result in acute adverse health effects, 
particularly during periods when respiratory protection is not worn.  These 
changes include transient reductions in spirometric measurements and increased 
airway reactivity.  Chronic respiratory effects may also occur, although the 
increased use of respiratory protection appears to have had a beneficial effect. 
Musk et al. (1979) found that following smoke exposure, the average decrease in 
FEV1 was 0.05 liters among firefighters and that this decline in FEV1 was related to the 
severity of smoke exposure as estimated by the firefighter and to the measured particulate 
concentration of the smoke to which he was exposed.  In addition, the effect of 
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pulmonary function impairment following exposure to house fires has shown a decrease 
in FEV1 with a small subgroup of firefighters who develop more substantial and 
potentially clinically important decreases in pulmonary function after smoke exposure 
(Large, 1990).   
Chattopadhyay et al. (2004) conducted a study on the effect of respiratory 
function of firefighters as a result of a chemical warehouse fire and found restrictive, 
obstructive and combined restrictive and obstructive types of pulmonary dysfunction as a 
result of exposure.  Research conducted by Sparrow et al. (1982) also found that 
firefighters had a greater loss of pulmonary function (FVC and FEV1) than non-
firefighters, which confirm earlier reports of a chronic effect of firefighting on pulmonary 
function and suggest an association of this occupation with increased respiratory 
symptoms and disease.   
Burgess et al. (2001) evaluated adverse respiratory effects following overhaul in 
firefighters.  A total of fifty-one firefighters were monitored for exposure to products of 
combustion to determine any changes in spirometric measurements and lung 
permeability.  Approximately half of the firefighters in the study wore no respiratory 
protection during overhaul while the other half wore cartridge respirators.  The results of 
the study revealed acute changes in spriometric measurements and lung permeability 
following firefighter overhaul even in those participants wearing full-face cartridge 
respirators.  Changes in FEV1 were associated with levels of specific products of 
combustion, demonstrating a dose-response relationship.  Based on the results of the 
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study, the authors recommend that a self-contained breathing apparatus continue to be 
used during overhaul. 
First responders are potentially exposed to a variety of chemicals in uncontrolled 
situations that could affect pulmonary function.  Spirometry data provides an opportunity 
to perform occupational health surveillance to evaluate pulmonary function impairment 
as well develop safe work practices in this industry with the ultimate goal of reducing 
chemical exposure. 
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Chapter 5 
Methods 
5.1 Study Population 
 A record review was conducted on pulmonary function tests from the workers of 
boat manufacturing companies, electric utility companies, and first responders in the state 
of Florida. Inclusion criteria included any worker over the age of eighteen whose 
respirator use required pulmonary function testing. Records included data for principal 
confounding factors regarding pulmonary function outcomes including smoking history, 
age, gender, and height.  
A standard population for comparison consisted of the NHANES III Raw 
Spirometry cohort, which consists of pulmonary function tests for 16,606 individuals 
sampled in the United States. The Raw Spirometry file was merged by respondent 
identification number with the NHANES III Household Adult Data file to obtain 
demographic and behavioral confounder data. The NHANES III control population was 
further restricted by age to reflect the age range of the study population and unacceptable 
tests were removed from analysis by technician quality code. Record reviews were 
approved under the University of South Florida Institutional Review Board (IRB) # 
00001348.  A copy of the IRB approval letter is presented in Appendix I. 
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5.2 Pulmonary Function 
 All study population pulmonary function testing was conducted using the Koko 
spirometry system.  The best attempt of a minimum of three spirometry trials was used 
for analysis in both the study population and the control population.  The pulmonary 
function test outcomes used for analysis included FEV1 and FVC.  All spirograms were 
reviewed by a licensed physician and spirograms not meeting American Thoracic Society 
acceptability and reproducibility criteria presented in Table 4 were removed from 
analysis. 
Table 4: American Thoracic Society Acceptability and Reproducibility Criteria 
ACCEPTABILITY CRITERIA 
Good start-of-test: 
• Extrapolated volume is less than 5% of FVC or 0.15 L, whichever is greater; 
• No hesitation or false start; 
• A rapid start to rise time; 
• No cough, especially during the first second on the maneuver; 
• No early termination of exhalation; 
• A minimum exhalation time of 6 seconds is recommended, unless there is an 
obvious plateau of reasonable duration or the subject cannot or should not 
continue to exhale further; 
• No maneuver should be eliminated solely because of early termination. 
REPRODUCIBILITY CRITERIA 
After three acceptable spirograms have been obtained, apply the following tests: 
• Are the two largest FVCs within 0.2L of each other? 
• Are the two largest FEV1s within 0.2L of each other? 
Number of trials: 
• A minimum of 3 acceptable FVC maneuvers should be performed. 
• If a subject is unable to perform a single acceptable maneuver after 8 attempts, 
testing may be discontinued. However, after additional instruction and 
demonstration, more maneuvers may be performed depending on the subject’s 
clinical condition and tolerance. 
(Adapted from American Association for Respiratory Care. AARC Clinical Practice 
Guideline: Spirometry, 1996 Update. Respiratory Care, Volume 41, Number 7, 629-636) 
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5.3 Statistical Analysis 
 The role of statistical analysis in research is vital because it gives meaning to the 
data that is collected.  The goal in any data analysis is to extract from raw information the 
accurate estimation (Alexopoulos, 2010).  The appropriate statistical tests chosen for this 
research are described in the paragraphs below. 
 To determine if the worker population experienced abnormal pulmonary function 
compared to the standard population, mean values were produced for FEV1 and FVC and 
the significance of the differences were evaluated using the students t-test.  These 
analyses were further stratified by median age, median height, gender, and smoking 
history.  To determine which factors were most predictive of pulmonary function, 
multivariate linear regression analysis was performed for the outcomes of FEV1 and 
FVC.  Linear regression is the procedure that estimates the coefficients of the linear 
equation, involving one or more independent variables that best predict the value of the 
dependent variable which should be quantitative (Alexopoulos, 2010).  Multivariate 
analysis evaluated the following variables as predictors of pulmonary function outcomes: 
age, gender, height, pack-years of smoking, and status as a worker. 
There is currently an active debate regarding the use of the FEV1/FVC ratio as a 
definitive criterion for the diagnosis of obstructive disorders, but it is generally 
acknowledged that lowered FEV1/FVC ratio is indicative of obstruction when taken into 
context with other pulmonary function testing data for the individual and patient 
demographics (Mohamed, 2011).  This research evaluated the study population for 
deficits at the higher end of the normal FEV1/FVC range, 0.80. A categorical approach 
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was used to evaluate potential pre-clinical pulmonary obstruction using logistic 
regression to evaluate associations with producing an abnormal FEV1/FVC ratio, defined 
as less than 0.80.  Logistic regression coefficients can be used to estimate odds ratios for 
each of the independent variables in the model (Alexopoulos, 2010).  Categories for 
independent variables were defined as above and below median height and median age, 
females vs. males, nonsmokers vs. those with a smoking history.  Statistical significance 
was determined by a p-value less than 0.05 for all analytical tests.  All statistical analyses 
were performed using SAS version 9.1.2. 
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Chapter 6 
Pulmonary Function Testing in Boat Manufacturer Workers 
6.1 Data Source 
 A record review was conducted on seventy-five pulmonary function tests from the 
workers of three boat manufacturing companies in the state of Florida based upon the 
inclusion criteria provided in the Chapter 5.1.  Restriction of the NHANES III data and 
removal of unacceptable spirometry tests resulted in a final control population of 4,729 
subjects. 
6.2 Results 
6.2.1 Univariate Analysis 
 The population demographics for both the study population (boat manufacturer 
workers) and the NHANES III segment used for analysis are reported in Table 5.  The 
study population was largely male and approximately forty-one percent had a history of 
tobacco smoking.  The study population was somewhat younger overall, compared to the 
NHANES III median age.   
 Figure 6 provides the results of means testing for FEV1 and FVC comparing the 
total study population to the NHANES III segment.  The study population demonstrated a 
modestly higher mean FEV1, while no statistically significant differences were found 
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between mean FVC values when comparing the populations as a whole.  The differences 
in age and disproportionate gender represented in the study population necessitated the 
use of stratified analysis to determine the effect of these population differences on 
evaluating the effect of boat manufacturer worker status on pulmonary function. 
 Stratification by age (below median), height, and smoking status yielded 
statistically significant larger mean values for FEV1 and FVC measurements for the 
study population. When analyzing females and those at or above median age, no 
statistically significant differences were found. The results of the analysis are reported in 
Figures 7 through 14. 
Table 5: Summary of Study Population and NHANES III Control Population 
 Study Population NHANES III 
Total population n = 75 4,729 
   
Males n = 66 3,446 
Females n = 9 1,283 
   
Smoking History (YES) 31 2,897 
Smoking History (NO) 44 1,832 
   
Median Height (Inches) 67 69 
Median Age (Years) 29 40 
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Figure 6: Pulmonary Function Mean for the Total Population.  Bolded values are statistically significant. 
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Figure 7: Pulmonary Function Mean for Males.  Bolded values are statistically significant
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Figure 8: Pulmonary Function Mean for Females 
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Figure 9: Pulmonary Function Mean for Smoking History (YES).  Bolded values are statistically significant. 
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Figure 10: Pulmonary Function Mean for Smoking History (NO).  Bolded values are statistically significant 
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Figure 11: Pulmonary Function Mean for Height At or Above Median (67 inches).  Bolded values are statistically significant. 
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Figure 12: Pulmonary Function Mean for Height Below Median (67 inches).  Bolded values are statistically significant. 
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Figure 13: Pulmonary Function Mean for Age at or Above Median (29 years) 
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Figure 14: Pulmonary Function Mean for Age Below Median (29 years).  Bolded values are statistically significant 
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6.2.2 Multivariate Analysis 
Multivariate analysis was conducted by constructing linear regression models 
including all data elements known to impact pulmonary function including age, height, 
gender, and smoking history.  The parameter estimates identify the magnitude of effect 
each predictor has on either increasing or decreasing pulmonary function in the total 
population.  Statistically significant predictors were identified as having a p-value less 
than 0.05.  The results of the linear regression analysis for FEV1 are reported in Table 6.  
The analysis identified age, height, gender, and smoking pack-years as statistically 
significant predictors of FEV1.  The adjusted outcome for status as a boat manufacturer 
worker was not a statistically significant predictor of FEV1. 
 The results of the linear regression analysis for FVC are reported in Table 7.  The 
analysis identified age, height, gender, but not smoking pack-years as statistically 
significant predictors of FVC.  The adjusted outcome for status as a boat manufacturer 
worker was also a significant predictor of FVC in this analysis.  With a parameter 
estimate of 0.2957, status as a boat manufacturer conferred a modest increase to FVC 
compared to the control population. 
 Logistic regression analysis was used to determine the effect of pulmonary 
function predictors on generating an FEV1/FVC ratio less than 0.80 (Table 8).  From this 
analysis, two statistically significant factors impacted the FEV1/FVC ratio: age and 
smoking history.  Height, gender, and status as a boat manufacturer worker were not 
associated with the production of a FEV1/FVC ratio less than 0.80. Those in the 
population over the median age for boat manufacturer workers (29) were approximately 
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twice as likely to produce an FEV1/FVC ratio less than 0.80.  Similarly, those with no 
smoking history were nearly half as likely to produce an FEV1/FVC ratio less than 0.80. 
Table 6: Predictors of FEV1 from Linear Regression Analysis 
FEV1 
Predictor Parameter Estimate Standard Error p-value 
Age at test -0.0394 0.0017 <0.0001 
Height at test (in) 0.0829 0.0057 <0.0001 
Gender (females vs. males) -0.6491 0.0376 <0.0001 
Smoking History (pk-yrs) -0.0034 0.0011 0.0030 
Boat Manufacturer Status 0.1077 0.0706 0.1276 
Bolded values are statistically significant. 
Table 7: Predictors of FVC from Linear Regression Analysis 
 
FVC 
Predictor Parameter Estimate Standard Error p-value 
Age at test -0.0328 0.0021 <0.0001 
Height at test (in) 0.1063 0.0070 <0.0001 
Gender (females vs. males) -0.8538 0.0461 <0.0001 
Smoking History (pk-yrs) 0.0023 0.0014 0.0951 
Boat Manufacturer Status 0.2957 0.0865 0.0006 
Bolded values are statistically significant. 
Table 8: Logistic Regression Analysis of FEV1/FVC to Examine the Effect of Predictors 
on Producing an Abnormal Ratio (<0.80 FEV1/FVC) 
 
FEV1/FVC <0.80 
Predictor Odds Ratio 95% Confidence Limit 
Age above median >29 years 2.16 1.82 – 2.56 
Height above median >67 inches 1.11 0.97 – 1.27 
Gender (females vs. males) 0.92 0.80 – 1.07 
Smoking History (effect on non-smoking) 0.55 0.48 – 0.62 
Boat Manufacturer Status 0.96 0.59 – 1.56 
Bolded values are statistically significant. 
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6.3 Discussion 
This research examined the feasibility of conducting a cross sectional surveillance 
evaluation of workers in the boat manufacturing industry from three boat manufacturing 
facilities in the state of Florida, which had maintained records of pulmonary function 
testing for workers required to use respiratory protection.  Statistical comparisons 
between the occupational population and the NHANES III population segment, limited 
by age and height to reflect the occupational population’s demographics, demonstrated 
the putative factors that altered pulmonary function in our population of interest. 
The results of this research indicated that the boat manufacturer workers 
experienced a modest, but statistically significant, increase in FEV1 mean values over the 
NHANES III population in both total and stratified analyses, including stratification by 
gender, age, height, and smoking history.  While the analysis of the total population for 
FVC mean values did not demonstrate a difference from the control population, stratified 
analyses demonstrated modest, significant increases in mean FVC for some stratified 
analyses by gender, age, height, and smoking history.  No analysis that examined mean 
values demonstrated better pulmonary function in the control group versus the target 
worker population. 
 In the linear regression analysis performed to examine the effect of salient 
cofactors on pulmonary function, FEV1 analysis demonstrated that age, height, gender, 
and smoking pack-years all significantly affected pulmonary function of the population in 
the expected direction.  That is to say, increased age, female gender, and increased pack-
years of smoking decreased FEV1, while increased height increased FEV1.  Status as a 
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boat manufacturer worker was not found to have a statistically significant effect on 
FEV1. 
Similar results were reported for the analysis of FVC, with the exception of pack-
year history of smoking, which did not demonstrate statistical significance in this 
analysis.  As well, status as a boat manufacturer worker conferred a modest, significant 
increase in FVC.  The results of the linear regression analysis for FEV1 and FVC 
outcomes indicate that the predominate factors that affect pulmonary function values are 
those traditionally known to impact lung volume and clearance, e.g. age, height, gender, 
and smoking history.  A modest positive effect on FVC was observed for boat 
manufacturer workers in both the stratified analysis, as well as the linear regression 
analysis.  This may indicate the presence of the ‘healthy worker effect’ in the 
occupational population related to more time spent in active labor compared to the 
NHANES III population which may contain unemployed persons or those engaged in 
more sedentary labor. 
Logistic regression was performed for the outcome of the FEV1/FVC ratio to 
evaluate the potential for obstructive disorders among the target occupational population 
compared to the NHANES III population.  A cutoff point of less than 0.80 FEV1/FVC 
was used to classify persons with abnormal FEV1/FVC values that could potentially be 
an indicator of pre-clinical pulmonary obstruction.  In this analysis, status as a boat 
manufacturer worker was not significantly associated with an FEV1/FVC value of less 
than 0.80.  However, the analysis clearly demonstrated that the older half of the 
population was twice as likely to produce a lower FEV1/FVC ratio, and non-smokers 
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were half as likely to produce a lower FEV1/FVC ratio compared to the smokers in the 
population. 
Through the use of OSHA mandated pulmonary function testing and the available 
NHANES III spirometry data set, this study was able to efficiently evaluate the 
pulmonary health of a substantive cross section of a specific industry: boat manufacturer 
workers.  The data collected in both the OSHA mandated testing and the NHANES III 
spirometry data allows for the control of confounding factors that impact measures of 
pulmonary function so that statistical comparisons can identify deficits in pulmonary 
function and indicate whether or not those deficits are associated with an occupational 
sector.  This research did not identify any pulmonary function deficits in the target 
occupational population and it demonstrated that in all cases boat manufacturer workers 
had equivalent or modestly superior pulmonary function compared to a baseline 
population. 
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Chapter 7 
Pulmonary Function Testing in Utility Workers 
7.1 Data Source 
 A record review was conducted on 227 pulmonary function tests from a 
population currently employed as utility workers in the state of Florida based upon the 
inclusion criteria provided in Chapter 5.1.  Restriction of the NHANES III data and 
removal of unacceptable spirometry tests resulted in a final control population of 4,958 
subjects.  There were only two females in the worker population; therefore females were 
removed from both the worker and NHANES III population for analysis. 
7.2 Results 
7.2.1 Univariate Analysis 
The population demographics for both the study population (utility workers) and 
the NHANES III segment used for analysis are reported in Table 9.  Approximately 
forty-one percent of the study population had a history of tobacco smoking and was 
slightly older overall, compared to the NHANES III mean age. 
Figure 15 provides the results of means testing for FEV1 and FVC comparing the 
total study population to the NHANES III segment.  The study population demonstrated 
modestly higher (statistically significant) mean values for FEV1 and FVC when 
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compared to the NHANES III control population.  The difference in age represented in 
the study population necessitated the use of stratified analysis to determine the effect of 
the population difference on evaluating the effect of utility worker status on pulmonary 
function. 
No significant differences were found between mean pulmonary function test 
values of utility workers and NHANES III study subjects when stratified by age, height, 
and smoking status except among older utility workers, who demonstrated modestly 
better pulmonary function values compared to their NHANES III counterparts.  The 
results of the analysis are reported in Figures 15 through 21. 
Table 9: Summary of Study Population and NHANES III Control Population 
 Study Population NHANES III 
Total population n = 225 4958 
   
Males n = 225 4958 
Females n = 0 0 
   
Smoking History (YES) 93 3144 
Smoking History (NO) 132 1814 
   
Mean Height (Inches) 70 69 
Mean Age (Years) 45 41 
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Figure 15: Pulmonary Function Mean for the Total Population.  Bolded values are statistically significant. 
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Figure 16: Pulmonary Function Mean for Smoking History (YES) 
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Figure 17: Pulmonary Function Mean for Smoking History (NO) 
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Figure 18: Pulmonary Function Mean for Height At or Above Median (70 inches) 
 
3.99 
5.08 
3.94 
5.04 
0"
1"
2"
3"
4"
5"
6"
FEV1"(Liters)" FVC"(Liters)"
Study"Popula?on"
NHANES"III"
95
%
 C
I =
 3
.8
8 
- 4
.1
0 
95
%
 C
I =
 3
.9
1 
- 3
.9
7 
p-
va
lu
e 
= 
0.
45
11
 
95
%
 C
I =
 4
.9
5 
- 5
.2
1 
95
%
 C
I =
 5
.0
0 
- 5
.0
7 
p-
va
lu
e 
= 
0.
53
58
 
81"
"
 
Figure 19: Pulmonary Function Mean for Height Below Median (70 inches) 
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Figure 20: Pulmonary Function Mean for Age At or Above Median (46 years).  Bolded values are statistically significant. 
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Figure 21: Pulmonary Function Mean for Age Below Median (46 years) 
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7.2.2 Multivariate Analysis 
 Multivariate analysis was conducted by constructing linear regression models 
including all data elements known to impact pulmonary function including age, height, 
and smoking history.  The parameter estimates identify the magnitude of effect each 
predictor has on either increasing or decreasing pulmonary function in the total 
population.  Statistically significant predictors were identified as having a p-value less 
than 0.05.  The results of the linear regression analysis for FEV1 are reported in Table 10. 
The analysis identified age, height, pack-years of smoking, and utility worker status as 
statistically significant predictors of FEV1.  
 The results of the linear regression analysis for FVC are reported in Table 11.  
The analysis identified age and height, but not smoke pack-years as statistically 
significant predictors of FVC.  The adjusted outcome for status as a utility worker was 
also a significant predictor of FVC in this analysis. With a parameter estimate of 0.2460, 
status as a utility worker conferred a modest increase to FVC compared to the control 
population. 
 Logistic regression analysis was used to determine the effect of pulmonary 
function predictors on generating an FEV1/FVC ratio less than 0.80 (Table 12).  From 
this analysis, three statistically significant factors impacted the FEV1/FVC ratio: age, 
height, and smoking history. Status as a utility worker was not associated with the 
production of a FEV1/FVC ratio less than 0.80.  Those in the population over the median 
age for utility workers (forty-six) were approximately four times as likely to produce an 
FEV1/FVC ratio less than 0.80.  Those in the population over the median height for 
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utility workers (seventy-one) were approximately one and a half times as likely to 
produce an FEV1/FVC ratio less than 0.80.  Similarly, those with no smoking history 
were nearly half as likely to produce an FEV1/FVC ratio less than 0.80. 
Table 10: Predictors of FEV1 from Linear Regression Analysis 
FEV1 
Predictor Parameter Estimate Standard Error p-value 
Age at test -0.03842 0.00141 <0.0001 
Height at test (in) 0.08397 0.00486 <0.0001 
Smoking History (pk-yrs) -0.00314 0.00107 0.0034 
Utility Worker Status 0.30053 0.04526 <0.0001 
Bolded values are statistically significant. 
Table 11: Predictors of FVC from Linear Regression Analysis 
 
FVC 
Predictor Parameter Estimate Standard Error p-value 
Age at test -0.03168 0.00169 <0.0001 
Height at test (in) 0.11685 0.00583 <0.0001 
Smoking History (pk-yrs) 0.00199 0.00128 0.1221 
Utility Worker Status 0.24602 0.05425 0.0006 
Bolded values are statistically significant. 
Table 12: Logistic Regression Analysis of FEV1/FVC to Examine the Effect of 
Predictors on Producing an Abnormal Ratio (<0.80 FEV1/FVC) 
 
FEV1/FVC <0.80 
Predictor Odds Ratio 95% Confidence Limit 
Age above median >29 years 3.86 3.39 – 4.40 
Height above median >67 inches 1.48 1.30 – 1.70 
Smoking History (effect on non-smoking) 0.57 0.51 – 0.65 
Utility Worker Status 1.30 0.97 – 1.74 
Bolded values are statistically significant. 
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7.3 Discussion 
This research examined the feasibility of conducting a cross sectional surveillance 
evaluation of workers in the utility industry from seven utility facilities in the state of 
Florida, which had maintained records of pulmonary function testing for workers 
required to use respiratory protection.  Statistical comparisons between the occupational 
population and the NHANES III population segment, limited by age and height to reflect 
the occupational population’s demographics, demonstrated the putative factors that 
altered pulmonary function in the population of interest. 
The results of this research indicated that the utility workers experienced a 
modest, but statistically significant, increase in FEV1 and FVC compared to the 
NHANES III population for the total analysis.  No significant differences were found 
between mean pulmonary function test values of utility workers and NHANES III study 
subjects when stratified by age, height, and smoking status except among older utility 
workers, who demonstrated modestly better FEV1 and FVC values compared to the study 
population.  
In the linear regression analysis performed to examine the effect of salient 
cofactors on pulmonary function, FEV1 analysis demonstrated that age, height, smoking 
history, and utility worker status significantly affected pulmonary function.  As expected, 
increased age and increased pack-years of smoking decreased FEV1, while increased 
height increased FEV1.  The results of this analysis also revealed that status as a utility 
worker was associated with a significant increase in FEV1. 
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Similar results were reported for the analysis of FVC, with the exception of 
smoking history, which did not demonstrate statistical significance in this analysis.  As 
with FEV1, status as a utility worker conferred a modest, significant increase in FVC.  
The results of the linear regression analysis for FEV1 and FVC outcomes indicate that the 
predominate factors that affect pulmonary function values are those traditionally known 
to impact lung volume and clearance, e.g. age, height, and smoking history.  A modest 
positive effect on FEV1 and FVC was observed for utility workers in both the stratified 
analysis, as well as the linear regression analysis.  This may indicate the presence of the 
‘healthy worker effect’ in the occupational population related to more time spent in active 
labor compared to the NHANES III population which may contain unemployed persons 
or those in more sedentary labor. 
Logistic regression was performed for the outcome of the FEV1/FVC ratio to 
evaluate the potential for obstructive disorders among the target occupational population 
compared to the NHANES III population. A cutoff point of less than 0.80 FEV1/FVC 
was used to classify persons with abnormal FEV1/FEV values that could potentially be 
an indicator of pre-clinical pulmonary obstruction. In this analysis, status as a utility 
worker was not significantly associated with an FEV1/FVC value of less than 0.80.  
However, the analysis clearly demonstrated that the older half of the population and those 
above the median height were more likely (odds ratio of 3.86 and 1.48 respectively) to 
produce a lower FEV1/FVC ratio, and non-smokers were approximately half as likely to 
produce a lower FEV1/FVC ratio compared to the smokers in the population. 
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Through the use of OSHA mandated pulmonary function testing and the available 
NHANES III spirometry data set, this study was able to efficiently evaluate the 
pulmonary health of a substantive cross section of a specific industry: utility workers.  
The data collected in both the OSHA mandated testing and the NHANES III spirometry 
data allows for the control of confounding factors that impact measures of pulmonary 
function so that statistical comparisons can identify deficits in pulmonary function and 
indicate whether or not those deficits are associated with an occupational sector.  This 
research did not identify any pulmonary function deficits in the target occupational 
population and it demonstrated that in all cases, electric utility workers had equivalent or 
modestly superior pulmonary function compared to a baseline population. 
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Chapter 8 
Pulmonary Function Testing in Emergency Responders 
8.1 Data Source 
 A record review was conducted on 127 pulmonary function tests from emergency 
responders in the state of Florida based upon the inclusion criteria provided in Chapter 
5.1. Restriction of the NHANES III data and removal of unacceptable spirometry tests, 
resulted in a final control population of 9,792 subjects. 
8.2 Results 
8.2.1 Univariate Analysis 
 The population demographics for both the study population (emergency 
responders) and the NHANES III segment used for analysis are reported in Table 13.  
The study population was largely male and approximately 16 percent had a history of 
tobacco smoking.  The study population was slightly younger and taller overall, 
compared to the NHANES III mean age and height. 
 Figure 22 provides the results of means testing for FEV1 and FVC comparing the 
total study population to the NHANES III segment.  The study population demonstrated 
modestly higher mean FEV1 and FVC values when comparing the populations as a 
whole.  The differences in age and disproportionate gender represented in the study 
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population necessitated the use of stratified analysis to determine the effect of these 
population differences on evaluating the effect of emergency worker status on pulmonary 
function. 
 Stratification by age, gender, height and smoking history yielded statistically 
significant larger mean values for FEV1 and FVC measurements for the study 
population.  The results of the analysis are reported in Figures 23 through 30. 
Table 13: Summary of Study Population and NHANES III Control Population 
 Study Population NHANES III 
Total population n = 127 9792 
   
Males n = 105 4659 
Females n = 22 5133 
   
Smoking History (YES) 20 5176 
Smoking History (NO) 107 4616 
   
Mean Height (Inches) 69 66 
Mean Age (Years) 38 40 
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Figure 22: Pulmonary Function Mean for the Total Population.  Bolded values are statistically significant. 
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Figure 23: Pulmonary Function Mean for Males.  Bolded values are statistically significant. 
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Figure 24: Pulmonary Function Mean for Females.  Bolded values are statistically significant. 
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Figure 25: Pulmonary Function Mean for Smoking History (YES).  Bolded values are statistically significant. 
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Figure 26: Pulmonary Function Mean for Smoking History (NO).  Bolded values are statistically significant. 
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Figure 27: Pulmonary Function Mean for Height At or Above Median (70 inches).  Bolded values are statistically significant. 
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Figure 28: Pulmonary Function Mean for Height Below Median (70 inches).  Bolded values are statistically significant. 
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Figure 29: Pulmonary Function Mean for Age At or Above Median (38 years).  Bolded values are statistically significant. 
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Figure 30: Pulmonary Function Mean for Age Below Median (38 years).  Bolded values are statistically significant. 
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8.2.2 Multivariate Analysis 
 Multivariate analysis was conducted by constructing linear regression models 
including all data elements known to impact pulmonary function including age, height, 
gender, and smoking history.  The parameter estimates identify the magnitude of effect 
each predictor has on either increasing or decreasing pulmonary function in the total 
population. Statistically significant predictors were identified as having a p-value less 
than 0.05.  The results of the linear regression analysis for FEV1 are reported in Table 14. 
The analysis identified age, height, gender and smoking history as statistically significant 
predictors of FEV1.  The adjusted outcome for status as an emergency responder was 
also a significant predictor of FEV1 in this analysis. With a parameter estimate of 
0.44757, status as an emergency responder conferred a modest increase to FEV1 
compared to the control population. 
 The results of the linear regression analysis for FVC are reported in Table 15.  
The analysis identified age, height, gender, but not smoking history as statistically 
significant predictors of FVC.  The adjusted outcome for status as an emergency 
responder was also a significant predictor of FVC in this analysis.  With a parameter 
estimate of 0.53683, status as an emergency responder conferred a modest increase to 
FVC compared to the control population. 
 Logistic regression analysis was used to determine the effect of pulmonary 
function predictors on generating an FEV1/FVC ratio less than 0.80 (Table 16).  From 
this analysis, four statistically significant factors impacted the FEV1/FVC ratio: age, 
height, smoking history, and gender.  Status as an emergency responder was not 
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associated with the production of a FEV1/FVC ratio less than 0.80.  Those in the 
population over the median age (thirty-eight years) and height (seventy inches) were 
more likely to produce an FEV1/FVC ratio less than 0.80.  Similarly, those with no 
smoking history and gender is female were less likely to produce an FEV1/FVC ratio less 
than 0.80. 
Table 14: Predictors of FEV1 from Linear Regression Analysis 
FEV1 
Predictor Parameter Estimate Standard Error p-value 
Age at test -0.03571 0.00105 <0.0001 
Height at test (in) 0.07459 0.00357 <0.0001 
Gender  -0.62706 0.02694 <0.0001 
Smoking History (pk-yrs) -0.00391 0.00083 <0.0001 
Emergency Responder Status 0.44757 0.05049 <0.0001 
Bolded values are statistically significant. 
Table 15: Predictors of FVC from Linear Regression Analysis 
FVC 
Predictor Parameter Estimate Standard Error p-value 
Age at test -0.02927 0.00124 <0.0001 
Height at test (in) 0.10485 0.00423 <0.0001 
Gender  -0.81338 0.03188 <0.0001 
Smoking History (pk-yrs) -0.00102 0.00098 0.2987 
Emergency Responder Status 0.53683 0.05974 <0.0001 
Bolded values are statistically significant. 
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Table 16: Logistic Regression Analysis of FEV1/FVC to Examine the Effect of 
Predictors on Producing an Abnormal Ratio (<0.80 FEV1/FVC) 
FEV1/FVC <0.80 
Predictor Odds Ratio 95% Confidence Limit 
Age above median >38 years 3.5 3.20 – 3.80 
Height above median >70 inches 1.4 1.24 – 1.59 
Gender (females vs. males) 0.55 0.50 – 0.60 
Smoking History (effect on non-smoking) 0.76 0.69 – 0.84 
Emergency Responder Status 0.93 0.66 – 1.35 
Bolded values are statistically significant. 
8.3 Discussion 
 This research examined the feasibility of conducting a cross sectional surveillance 
evaluation of workers in the emergency response industry in the state of Florida, which 
had maintained records of pulmonary function testing for workers required to use 
respiratory protection. Statistical comparisons between the occupational population and 
the NHANES III population segment, limited by age and height to reflect the 
occupational population’s demographics, demonstrated the putative factors that altered 
pulmonary function in the population of interest. 
 The results of this research indicated that the emergency responders experienced a 
modest, but statistically significant, increase in FEV1 and FVC mean values over the 
NHANES III population in both total and stratified analyses, including stratification by 
age, gender, height, and smoking history. No analysis that examined mean values 
demonstrated better pulmonary function in the control group versus the target worker 
population. 
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 In the linear regression analysis performed to examine the effect of salient 
cofactors on pulmonary function, FEV1 analysis demonstrated that age, gender, height 
and smoking history all significantly affected pulmonary function of the population in the 
expected direction. That is to say, increased age, female gender, and increased pack-years 
of smoking decreased FEV1, while increased height increased FEV1. As well, status as 
an emergency responder conferred a modest, significant increase in FEV1. 
 Similar results were reported for the analysis of FVC, with the exception of 
smoking history, which did not demonstrate statistical significance in this analysis.  The 
results of the linear regression analysis for FEV1 and FVC outcomes indicate that the 
predominate factors that affect pulmonary function values are those traditionally known 
to impact lung volume and clearance, e.g. age, gender, height, and smoking history.  A 
modest positive effect on FEV1 and FVC was observed for emergency responders in both 
the stratified analysis, as well as the linear regression analysis.  This may indicate the 
presence of the ‘healthy worker effect’ in the occupational population related to more 
time spent in active labor compared to the NHANES III population which may contain 
unemployed persons or those engaged in more sedentary labor. 
 Logistic regression was performed for the outcome of the FEV1/FVC ratio to 
evaluate the potential for obstructive disorders among the target occupational population 
compared to the NHANES III population.  A cutoff point of less than 0.80 FEV1/FVC 
was used to classify persons with abnormal FEV1/FVC values that could potentially be 
an indicator of pre-clinical pulmonary obstruction.  In this analysis, status as an 
emergency responder was not significantly associated with an FEV value of less than 
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0.80.  However, the analysis clearly demonstrated that the older and taller half of the 
population was more likely to produce a lower FEV1/FVC ratio, and non-smokers and 
the female gender were less likely to produce a lower FEV1/FVC ratio compared to the 
smokers and males in the population. 
 Through the use of OSHA mandated pulmonary function testing and the available 
NHANES III spirometry data set, this study was able to efficiently evaluate the 
pulmonary health of a substantive cross section of a specific industry: emergency 
responders.  The data collected in both the OSHA mandated testing and the NHANES III 
spirometry data allows for the control of confounding factors that impact measures of 
pulmonary function so that statistical comparison can identify deficits in pulmonary 
function and indicate whether or not those deficits are associated with an occupational 
sector.  This research did not identify any pulmonary function deficits in the target 
occupational population and it demonstrated that in all cases, emergency responders had 
modestly superior pulmonary function compared to a baseline population. 
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Chapter 9 
Conclusion 
 Occupational health surveillance in the United States is a rising priority and a new 
focus has been established on the health and welfare of the workforce.  Health 
surveillance in the past has typically been associated with communicable diseases such as 
polio and influenza.  However, as Baker et al. (1988) states: 
  Although certain aspects of the communicable disease surveillance model 
are applicable for surveillance of occupational conditions, there are basic 
differences between communicable diseases and occupational disorders which 
impact on the strategy for surveillance: 
• Strong disincentives exist for reporting occupational conditions by 
employers, physicians, and most importantly affected individuals.  Such 
disincentives do not characterize communicable disease surveillance. 
• Health professionals lack knowledge regarding the nature of health risks in 
the workplace. Generally, they are more familiar with communicable 
disease surveillance. 
• Many common occupational conditions are also caused or aggravated by 
non-occupational factors unrelated to work. 
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• The latency period between exposure onset and disease occurrence is 
frequently great for occupational disorders. 
While the history of occupational diseases may go back for centuries, numerous 
diseases and ailments go unrecognized in modern times.  Currently, the nation’s 
workforce is exposed to more potential hazards than ever before.  In the past, the points 
listed above have hindered the identification of the occupational origin of numerous 
diseases.  Fortunately, a new emphasis on worker health has been established at the 
corporate level, employee level, and in academic institutions.  Corporations recognize the 
economic impact and loss of productivity that can occur when an employee has to miss 
work or becomes disabled.  Employees now more than ever realize the negative impact 
associated with being out of work and how it affects not only them, but also other 
household members dependent on both their physical and monetary support.   
Increased awareness of the importance of a healthy workforce has created a need 
for public health practitioners specialized in occupational health.  Companies are now 
seeking individuals that have knowledge of the health risks associated with the workplace 
and the ability to monitor their workforce and implement controls when needed.  This has 
led to the development of occupational health courses and degrees being offered to a 
variety of disciplines including physicians, toxicologists, industrial hygienists, and 
epidemiologists.  Better understanding of occupational settings, occupational diseases, 
and surveillance strategy has led to the advancement of occupational health surveillance. 
The stated objectives of this study were to: 
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• Identify industries in the State of Florida that have the potential for increased 
pulmonary impairment amongst workers. 
• Evaluate the feasibility of using pulmonary function data collected for purposes of 
compliance and/or best practices for workers who use respiratory protection 
because they are potentially exposed to pulmonary toxicants in the workplace.  
OSHA mandated pulmonary function testing as well as testing included as a best 
practice or standard operating procedure represents a potentially powerful surveillance 
tool to evaluate at-risk populations who have known inhalation exposures that require 
respiratory personal protective equipment and regular spirometry evaluations.  Evaluation 
of this type of occupational health data can lead to the advancement of occupational 
exposure controls as well as regulatory and policy changes that can lead to safer 
workplace environments.  In addition, this type of research can be expanded and or 
tailored to include additional indicators of occupational disease, which allows for greater 
utility and the potential to identify various adverse health effects associated with 
occupational exposure to toxicants. 
The methodology presented in this study provided an opportunity to determine the 
feasibility of using pulmonary function data collected for purposes of compliance and/or 
best practices for workers who use respiratory protection.  The various methods used for 
data collection and data analysis in this study indicated the feasibility of using 
occupational health data to quickly and efficiently conduct a population level analysis 
and draw conclusions.  Limitations of the interpretation of surveillance data can include 
under-reporting, reporting bias, and inconsistent case definitions.  While procedures were 
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established to address such limitations, further methods could be included to enhance the 
results. For example, additional analyses for consideration could include time 
comparative studies that track health outcomes through out a work history.  Inclusion of 
this additional analysis may help address biases associated with a one time study.  This 
study not only demonstrates the feasibility of using occupational health data for 
population level analysis but also illustrates the flexibility provided by the methodology 
presented. 
Two main limitations to conducting this line of research include data collection 
and data warehousing. The first principal limitation to conducting this line of research is 
access to occupational health data.  While all states require disease reporting, state and 
federal laws do not mandate that all occupational health data is reported and pooled for 
analysis.  Convincing industry to share this type of data is necessary to perform wide 
scale analyses and draw strong conclusions.  Ethical issues and legal issues related to 
occupational health surveillance include right of access, public trust, confidentiality, 
informed consent, etc.  Such concerns by industry need to be addressed and safeguards 
need to be established to ensure that dissemination of such data is only provided to those 
who need it for surveillance purposes.  Cooperation and education between governmental 
and private sectors to create acceptable data collection procedures that ensure ethical and 
legal concerns must be addressed and are key in the promotion of occupational health 
surveillance. 
The second principal limitation to conducting this line of research is the current 
lack of infrastructure to aggregate both required and voluntary pulmonary function 
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testing data.  OSHA required pulmonary function testing is conducted under standard 
pulmonary function testing guidelines and the resulting data is maintained with 
employers for compliance purposes.  If this data were also transmitted to a local, state, or 
federal database to be used in population level analysis, the availability and efficacy of 
this method of surveillance would be greatly enhanced.  Data sharing has many 
limitations, which include coding, formatting, definitions, etc.  Standardization of 
occupational health data for the purpose of data sharing and data processing need to be 
addressed and guidance created to eliminate the many different inconsistencies that exist 
in the equipment used and the data produced.  Advancement in technology and the 
increased awareness of the importance of data sharing should drive the needed 
advancements and collaboration to ensure that occupational health surveillance can be 
used to monitor health, which is in everyone’s best interest. 
There is a need to develop and utilize surveillance methodologies that are capable 
of efficiently evaluating occupational populations for health status, identifying changes in 
health status over time, and comparing the health status of occupational populations o 
baseline populations.  As shown by the methodology described in this study, the use of 
spirometry data to quickly evaluate the pulmonary health status of selected occupational 
populations is both a feasible and efficient way to conduct occupational health 
surveillance.   
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